As part of the Biomat-IN goal to stimulate international cooperation between companies active in the field of Biomedical materials, we are pleased to announce the launch of :
The opened international Innovation Voucher
"Call for Voucher"
Duration: until February 2014
Objective: The voucher is aimed at validating the feasibility of an SME-based early stage joint innovation project by granting free research and advice from one or several knowledge providers in the partner regions.
Amount: up to € 10,000 (including VAT) of the service provided.
For more information, and how to apply : click here
Biomaterials, materials intended to interface with biological systems, are now used in many medical applications, including: contact lenses, dental restoration, heart valves and prosthetic hips …
Directly linked to the extension of life expectancy and the need for a better quality of life, biomaterials are being used more and more in innovative medical applications...
Based on advanced techniques of polymer chemistry, biotechnology, cell and tissue engineering, the application of innovative biomaterials will require new strategies for multidisciplinary research, involving academics and industrial partners.
Biomat-IN gathers 5 European clusters willing to pool their resources in order to foster innovation in the field of biomaterials through transnational cooperation: Eurasanté and Atlanpole Biotherapies in France, Bioregio Stern in Germany, Medilink EM in the UK and LIOF in the Netherlands.
■ 4th Biomat-IN Special Interest Group : Challenge in new technologies for dental and musculoskeletal regeneration, from Science to Regulatory and Industrial applications
The 4th SIG Biomat-IN will be held on June 6th, 2013, in Nantes, France, at the same time as the 6th International Symposium on Apatite and Correlative Biomaterials (ISACB6).
This event will be focus on the challenge in new technologies for dental and musculoskeletal regeneration, from Science to Regulatoty and Industrial applications.
Two speakers will present the plenary session from a dual (scientific, regulatory) viewpoint :
"Challenges of the third millenium in Bone regeneration and Biomaterials", Guy Daculsi, LIOAD,
"What about Market approval for new biomaterials, tissue engineering, Drug Delivery System and Bone and cartilage regeneration, the EC and US regulatory point of view", Gaëlle Clermont, NAMSA.